Insights Directory



Affichage de - 12 éléments sur 179

  • Cyber Security Quarterly Update - Q2 2025

    CG's Cyber Security Update for Q2 2025 provides an update on the current market landscape including valuation trends, and recent public and private transaction activity.

    Technology

  • NewSpace, Business in the Final Frontier: A Conversation with Austin Moeller, CG’s Aerospace and Defense Technology Analyst

    Austin Moeller, CG’s Senior Aerospace and Defense Technology Analyst, joins Michael Graham, Director of Research and Investment strategy to discuss the topical ideas in the space and travel markets.

    Industrials/Aerospace & Defense

    Écouter le podcast

  • M&A Environment Report - Q2 2025

    Consumer and Retail

    Healthcare

    Sustainability

    Technology

  • Sustainability Dashboard - May 2025

    Sustainability

  • Navigating Nervous Times - The Risks, Rewards, and Complexities of Neurological Indications: A Conversation with Sumant Kulkarni CG’s Biotechnology Senior Analyst

    Sumant Kulkarni, CG’s Senior Analyst covering Biotechnology with a focus on neuroscience joins Director of Research and Investment Strategy Michael Graham, CFA to discuss the intricacies of indications in his space, the ever-present opportunities and how drug research and development have evolved over time. Listen here:

    Healthcare

    Écouter le podcast

  • Digital Transformation Services Update - June 2025

    Technology

    Télécharger le rapport

  • Streamlining Workflows to Differentiate Customer Experience; A Conversation with Jacob Thaysen, PhD, CEO of Illumina

    Jacob Thaysen, PhD, CEO of Illumina joins CG’s Diagnostics & Life Science Tools Senior Analyst Kyle Mikson to discuss Illumina’s customer acquisition strategy and growth outlook based on its differentiated technology.

    Healthcare

    Écouter le podcast

  • Technology, Media, Marketing, and Information Services - May 2025

    Technology

    Télécharger le rapport

  • Inflammation and Immunology: The Latest on Drug Development Targeting Atopic Dermatitis with Edward Nash, CG’s Biotechnology Senior Analyst

    Edward Nash, CG’s Biotechnology Senior Analyst specializing in metabolic disease and I&I joins Michael Graham, Director of Research and Investment Strategy to discuss the biggest takeaways from his 2nd Annual I&I Symposium (short for Inflammation and Immunology).

    Healthcare

    Écouter le podcast

  • Checkup on the Software Sector: The Landscape for Apps and AI with DJ Hynes, CG‘s Applications Software Senior Analyst

    DJ Hynes, CG’s Applications Software Senior Analyst joins Michael Graham, Director of Research and Investment Strategy at the tail end of Q1 2025 earnings season to walk listeners through the most important trends in his space.

    Technology

    Écouter le podcast

  • Sustainability Dashboard - April 2025

    Sustainability

  • S Curves and Scaling Games: A Conversation on AI with Kingsley Crane, CG Senior Analyst of Infrastructure & Security Software

    Kingsley Crane, CG’s Infrastructure and Security Software Senior Analyst joins Michael Graham, Director of Research and Investment Strategy, to break down the most important themes in AI as well as important players in the space.

    Technology

    Écouter le podcast

By agreeing to save your details, your details will be stored in your browser for the duration of your session to make it simple to request additional reports.